Manhuyod, Cjhay J.
HRN: 23-15-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/13/2023
06/19/2023
IV
400mg
Q6
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes